US-based kidney care provider Monogram Health completed a $160m series B round yesterday that included health insurance provider Humana.
Private equity group TPG led the round through its private equity platform, TPG Capital, and it also featured venture capital firms Frist Cressey Ventures and Norwest Venture Partners.
Monogram provides clinical managed services and renal care for kidney disease across 20 US states in addition to in-home nephrology clinical services that are informed by big data technology.
The company’s team includes nephrologists, nurses, dieticians, pharmacists and social workers to not only treat kidney disease but slow its progression and help patients understand their condition.
Bill Frist, chairman of Monogram, said: “Welcoming TPG Capital alongside noted national and regional strategic investors further validates our industry leading kidney model of care.
“We look forward to working with the TPG team as Monogram further solidifies its role as the preeminent leader in personalised, compassionate and evidence-based kidney care for patients.”
Todd Sisitsky, co-managing partner of TPG Capital, has taken a board seat at Monogram in connection with the round. Frist Cressey Ventures participated in a $5m round for the company in February 2019 before joining Norwest in a $7m series A-1 round in May 2020.
